BMY

New York Stock Exchange

Bristol Myers Squibb Co. · Healthcare · Pharmaceuticals

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$115.27B

PE Ratio

17.5181

EV to Ebitda

8.3311

Earnings Yield

5.71%

Revenue (TTM)

$48.19B

Net Income (TTM)

$7.06B

Revenue (Annual YoY Growth)

-0.22%

Revenue (Quarterly YoY Growth)

1.30%

Profit Margin

14.64%

Return on Equity

39.90%

Debt to Equity Ratio

2.5518

Dividend Yield

4.38%

All fundamentals

Core10 fields›

Market Cap$115.27B

Revenue TTM$48.19B

Shares Outstanding2.04B

Float2025148725

Float Short1.44%

Days To Cover2.5135713454

Short Interest29363672.0

Insider Ownership0.25%

Relative Strength54.2

GARP1259

Growth Estimates19 fields›

Revenue Growth (Annual)-0.22%

Revenue Growth (Quarterly YoY)1.30%

Operating Revenue Growth (Annual)0.130607

Operating Revenue Growth (Quarterly YoY)0.013576

3-Year Revenue Growth1.45%

5-Year Revenue Growth2.54%

EPS Growth (Annual)178.37%

EPS Growth (Quarterly YoY)1404.52%

3-Year EPS Growth Rate5.47%

5-Year EPS Growth Rate0.00%

LT EPS Growth Estimates6.80%

EBITDA Growth (Annual)-0.37%

EBITDA Growth (Quarterly YoY)6.00%

CFO Growth (Annual)-6.81%

CFO Growth (Quarterly YoY)-55.53%

FCF Growth (Annual)-7.87%

FCF Growth (Quarterly YoY)-60.50%

Dividend Growth (Annual)2.89%

Dividend Growth (Quarterly YoY)1.61%

Operations28 fields›

Revenue TTM$48.19B

Gross Margin TTM65.89%

Gross Margin (Quarterly)66.24%

R&D % of Revenue TTM19.70%

R&D Expenses TTM$9.49B

Operating Margin TTM31.36%

Operating Margin (Quarterly)29.05%

Operating Expenses TTM$16.64B

Profit Margin TTM14.64%

Profit Margin (Quarterly)8.69%

Net Income TTM$7.06B

EPS TTM3.4587

EPS (Quarterly)0.5326

EBIT Margin TTM31.36%

EBIT Margin (Quarterly)29.05%

EBITDA Margin TTM39.90%

EBITDA Margin (Quarterly)37.31%

EBITDA TTM$19.23B

CFO % of Revenue TTM29.37%

CFO % of Revenue (Quarterly)15.79%

CFO TTM$14.16B

Cash Margin22.15%

Capex % of Revenue TTM2.72%

Capital Expenditures$1.31B

FCF % of Revenue TTM26.65%

FCF % of Revenue (Quarterly)12.83%

FCF TTM$12.85B

Fundamental Score8

Efficiency6 fields›

ROE39.90%

ROA7.56%

ROIC10.38%

CROCI18.89%

Stock Comp % (Quarterly)1.06%

Stock Comp % TTM1.15%

Valuation20 fields›

P/E (TTM)17.5181

P/E Forward9.6202

P/E Ex-Cash16.0068

P/S Forward2.6185

PEG Forward0.1172

P/CFO8.7294

P/FCF9.6203

EV/EBITDA (TTM)8.3311

EV/EBITDA Forward9.1099

EV/Revenues (TTM)3.3242

EV/Revenues Forward3.3911

EV/CFO10.3354

EV/FCF (TTM)12.4724

Price To Book6.6967

Price to Tangible Book-5.5284

Earnings Yield5.71%

FCF Yield10.39%

Dividend Yield4.38%

Payout Ratio118.29%

Value Score8

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)0.9313

Relative Profit Margin (Quarterly)0.66

Relative P/E0.7132

Relative P/S0.5447

Relative P/B1.0588

Relative Earnings Yield1.4021

Relative Dividend Yield1.1989

Relative ROE1.3497

Relative ROA0.7835

Relative ROIC0.7047

Relative Debt to Equity2.5833

Liquidity15 fields›

Cash Per Share5.2421

Current Ratio1.2551

Cash & ST Assets$10.67B

Total Debt$46.65B

Goodwill & Intangibles$40.86B

Total Assets$90.04B

Total Liabilities$71.53B

Shareholders Equity$18.47B

Debt to Equity2.5518

Debt to Assets53.78%

Interest Expense$1.89B

Times Interest Earned7.9931

CFO to Debt (TTM)0.2814

Debt to EBITDA (TTM)2.682

Goodwill % of Assets45.38%

Yields5 fields›

Dividend Yield4.38%

Payout Ratio118.29%

Earnings Yield5.71%

Buyback Yield0.00%

Shareholder Yield5.37%

Options Flow8 fields›

Call Volume13109

Put Volume6013

Put/Call Ratio0.4586925013349607

Call $ Volume1757973

Put $ Volume1117168

Put/Call $ Ratio0.6354864380738499

Call OI323129

Put OI278279